Therapeutics Seminar Series

These seminars are once a month and include a talk by a graduate student in the Therapeutics Graduate Program or in a Program faculty member’s lab, or a more senior investigator, either a Therapeutics faculty member or an outside investigator.

 

5/15/15 – Dana Farber/HCC Symposium on the Hamartoma syndromes and cancer biology

  • Symposium organized by David Kwiatkowski, MD, PhD – Professor and Leader DF/HCC Cancer Genetics Program, BWH.
  • Register for event at http://events.dfhcc.harvard.edu/events/74
  • Jimmy Fund Auditorium, Binney Street, DFCI, 8:30-4:00pm

5/08/15 – Therapeutics Seminar Series – Psychiatric Clinical Trials

  • George Papakostas, MD, Scientific Director of the MGH CTNI
  • Cannon Room, Building C, Harvard Medical School, 12:30-1:30pm

5/5/15 – Dissertation Defense Seminar – TTD Program

  • David Michael Raiser, Ph.D. Candidate in the Program in Biological and Biomedical Sciences: “Interrogation of the RP-MDM2-p53 Axis in Human Ribosomopathies”
  • Harvard Medical School, Tosteson Medical Education Center, 260 Longwood Ave., Room 260 at 3:00PM

5/1/15 – Dissertation Defense Seminar – TTD Program

  • Lincoln Wain Pasquina, Ph.D. Candidate in the Program in Biological and Biomedical Sciences, Subject: Microbiology and Immunobiology: “Discovery of a small molecule that inhibits D-alanylation of teichoic acids in Staphylococcus aureus”
  • Harvard Medical School, New Research Building, 77 Avenue Louis Pasteur, Room 1031 at 11:00am

4/28/15 – Dissertation Defense Seminar – TTD Program

  • Clare Felicity Malone, Ph.D. Candidate in Biological and Biomedical Sciences, Subject area: Genetics: “Diverse Approaches to Developing Combination Therapies for NF1-mutant Cancers”
  • Harvard Medical School, Tosteson Medical Education Center, 260 Longwood Ave., Room 250 at 1:00pm

4/27/15 – Dissertation Defense Seminar – TTD Program

  • Kristin Melissa Rose, Ph.D. Candidate in Biological and Biomedical Sciences: “A Zebrafish Model of Uveal Melanoma”
  • Harvard Medical School, New Research Building, 77 Avenue Louis Pasteur, Room 350 at 9:00AM

3/24/15 – Dana Farber Cancer Institute and DF/HCC Seminars in Oncology

  • Kevin Struhl, Ph.D., Professor, Harvard Medical School: “An Epigenetic Switch Linking Inflammation to Cancer and the Use of Metformin as an Anti-Cancer Drug”
  • Jimmy Fund Auditorium, 35 Binney Street, 4:00pm

3/10/15 – Dana Farber Cancer Institute and DF/HCC Seminars in Oncology

  • Patrick T. Gunning, Ph.D., Canada Research Chair & Associate Professor of Chemistry, University of Toronto
  • Jimmy Fund Auditorium, 35 Binney Street, 4:00pm